CVE-2023-31167
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal.
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.43%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in Schweitzer Engineering Laboratories SEL-5036 acSELerator Bay Screen Builder Software on Windows allows Relative Path Traversal. SEL acSELerator Bay Screen Builder software is distributed by SEL-5033 SEL acSELerator RTAC, SEL-5030 Quickset, and SEL Compass. CVE-2023-31167 and was patched in the acSELerator Bay Screen Builder release available on 20230602. Please contact SEL for additional details. This issue affects SEL-5036 acSELerator Bay Screen Builder Software: before 1.0.49152.778.
- CVSS 3.1
- 8.1 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- EPSS
- 0.43% probability · 36th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-22
- Affected
- selinc/sel-5036 acselerator bay screen builder
- Source
- security@selinc.com
References
- https://dragos.comNot Applicable
- https://selinc.com/support/security-notifications/external-reports/Vendor Advisory
- https://dragos.comNot Applicable
- https://selinc.com/support/security-notifications/external-reports/Vendor Advisory
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.